Literature DB >> 33415086

Splenectomy with Portoazygous Disconnection for Correction of Systemic Hemodynamic Disorders in Hepatic Cirrhosis Patients with Portal Hypertension: A Prospective Single-Center Cohort Study.

Dao-Bing Zeng1, Liang Di1, Qing-Liang Guo1, Jing Ding1, Xiao-Fei Zhao1, Shi-Chun Lu2.   

Abstract

Objective: To investigate the effect of splenectomy for correction of systemic hemodynamic disorders in hepatic cirrhosis patients with portal hypertension.
Methods: Hepatic cirrhosis patients with portal hypertension were enrolled from April 2015 to July 2018. Systemic hemodynamic parameters (heart rate, mean arterial pressure (MAP), cardiac output, and total peripheral vascular resistance (TPR)) were prospectively measured at baseline and 1 week, 1, 3, and 6 months, and 1, 2, and 3 years postoperatively. Paired analysis was conducted.
Results: Sixty-nine patients were eligible, and 55 (79.7%) cases had a history of upper gastrointestinal bleeding. Child-Pugh classification was grade A in 41 (59.4%) cases, grade B in 26 (37.7%) cases, and grade C in 2 (2.9%) cases. The heart rate was significantly higher at 1 week postoperatively versus the baseline (P < 0.001). Meanwhile, the heart rate was significantly lower from 3 months to 2 years postoperatively versus the baseline (P < 0.05). The MAP was significantly higher at 6 months to 2 years postoperatively versus the baseline (P < 0.05). At 1 month postoperatively and 6 months to 2 years, the cardiac output was significantly lower versus the baseline (P < 0.05). At 1 month postoperatively and 6 months to 2 years, the TPR was significantly higher versus the baseline (P < 0.05).
Conclusion: Splenectomy corrects systemic hemodynamic disorder in hepatic cirrhosis patients with portal hypertension, and the effect is rapid and durable.
Copyright © 2020 Dao-Bing Zeng et al.

Entities:  

Year:  2020        PMID: 33415086      PMCID: PMC7769657          DOI: 10.1155/2020/8893119

Source DB:  PubMed          Journal:  Can J Gastroenterol Hepatol        ISSN: 2291-2789


  23 in total

1.  GENERAL AND REGIONAL CIRCULATORY ALTERATIONS IN CIRRHOSIS OF THE LIVER.

Authors:  H A KONTOS; W SHAPIRO; H P MAUCK; J L PATTERSON
Journal:  Am J Med       Date:  1964-10       Impact factor: 4.965

2.  The cardiac output at rest in Laennec's cirrhosis.

Authors:  H J KOWALSKI; W H ABELMANN
Journal:  J Clin Invest       Date:  1953-10       Impact factor: 14.808

3.  Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites.

Authors:  J Llach; P Ginès; V Arroyo; A Rimola; L Titó; S Badalamenti; W Jiménez; J Gaya; F Rivera; J Rodés
Journal:  Gastroenterology       Date:  1988-02       Impact factor: 22.682

4.  Hemodynamic abnormalities and venous admixture in portal cirrhosis.

Authors:  R A Massumi; J C Rios; H E Ticktin
Journal:  Am J Med Sci       Date:  1965-09       Impact factor: 2.378

Review 5.  Covert and Overt Hepatic Encephalopathy: Diagnosis and Management.

Authors:  Kavish R Patidar; Jasmohan S Bajaj
Journal:  Clin Gastroenterol Hepatol       Date:  2015-07-09       Impact factor: 11.382

Review 6.  Mechanisms of decompensation and organ failure in cirrhosis: From peripheral arterial vasodilation to systemic inflammation hypothesis.

Authors:  Mauro Bernardi; Richard Moreau; Paolo Angeli; Bernd Schnabl; Vicente Arroyo
Journal:  J Hepatol       Date:  2015-07-17       Impact factor: 25.083

7.  Abnormal splenic artery diameter/hepatic artery diameter ratio in cirrhosis-induced portal hypertension.

Authors:  Dao-Bing Zeng; Chuan-Zhou Dai; Shi-Chun Lu; Ning He; Wei Wang; Hong-Jun Li
Journal:  World J Gastroenterol       Date:  2013-02-28       Impact factor: 5.742

8.  [Measurement of hepatic venous pressure gradient in liver cirrhosis: relationship with the status of cirrhosis, varices, and ascites in Korea].

Authors:  Moon Young Kim; Soon Koo Baik; Ki Tae Suk; Change Jin Yea; Il Young Lee; Jae Woo Kim; Seung Hwan Cha; Young Ju Kim; Soon Ho Um; Kwang-Hyub Han
Journal:  Korean J Hepatol       Date:  2008-06

Review 9.  Beta-blockers in portal hypertension: new developments and controversies.

Authors:  Dhiraj Tripathi; Peter C Hayes
Journal:  Liver Int       Date:  2013-11-20       Impact factor: 5.828

Review 10.  Cirrhotic cardiomyopathy.

Authors:  Soon Koo Baik; Tamer R Fouad; Samuel S Lee
Journal:  Orphanet J Rare Dis       Date:  2007-03-27       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.